FDA
approval
· 2014-11-28
FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (SUNRISE PHARMACEUTICAL, INC.)
Summary
FDA approved Sunrise Pharmaceutical, Inc.'s original application for sodium polystyrene sulfonate, a resin used to treat hyperkalemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)